Building a successful company requires more than just a good idea. It takes vision, leadership, and the ability to navigate the complexities of growth. Our CEO and Co-founder, Liran Belenzon (he/him), recently joined Evan M. on The Hard Part podcast to share his insights on fundraising in a competitive market, scaling a team, and building a thriving company culture. Hear Liran's take on the challenges and triumphs of leading an industry-changing company and discover how BenchSci is making a positive impact on the world of drug discovery. 🎧 Apple: https://lnkd.in/eiSke5MW 🎧 Spotify: https://lnkd.in/ebKe67vQ #AI #biotech #entrepreneurship #drugdiscovery
BenchSci
Software Development
Toronto, Ontario 26,534 followers
We empower scientists with the world’s most advanced biomedical artificial intelligence.
About us
BenchSci’s vision is to exponentially increase the speed and quality of life-saving research by empowering scientists with the world’s most advanced biomedical artificial intelligence. Backed by F-Prime, Gradient Ventures (Google’s AI fund), Inovia Capital, and TCV, our platform accelerates science at 16 of the top-20 pharmaceutical companies, and over 4,300 leading research centers worldwide. We’re a remote-first company recognized for our impact and culture as a Deloitte Tech Fast 50TM, CIX Top 10 Growth, Great Place to Work®, and top-ranked organization on Glassdoor.
- Website
-
http://www.benchsci.com
External link for BenchSci
- Industry
- Software Development
- Company size
- 201-500 employees
- Headquarters
- Toronto, Ontario
- Type
- Privately Held
- Founded
- 2015
- Specialties
- Antibody, Research, Machine Learning, Online Platform, Science, Artificial Intelligence, and Reagent
Locations
-
Primary
559 College St
201
Toronto, Ontario M6G 1A9, CA
Employees at BenchSci
-
Jeremy Epstein
A PM drawing on a long history in user research, engineering, and design to make better products for the enterprise by insuring we keep buyers and…
-
Sandip Bhattacharya
Senior Software Engineer |🇨🇦|Cloud Infra,Kubernetes,GCP,Observability,DevOps/SRE,Individual Contributor
-
Poria Kanozi
Passionate Healthcare & Tech Strategist | Driving Delivery & Customer Success in Hypergrowth Environments
-
Amit Bronner
Senior Staff Engineer at BenchSci
Updates
-
We’re thrilled that BenchSci has been named one of Canada’s Top Growing Companies of 2024 by The Globe and Mail! 🎉 Canada’s Top Growing Companies ranks Canadian businesses based on their three-year revenue growth. We’ve earned our spot with an impressive three-year growth rate of 191%! 📈 This incredible milestone is a testament to our amazing team’s dedication and commitment. A heartfelt thank you to our team, customers, and partners. Your trust and support have been instrumental in making this achievement possible. Read more here: https://lnkd.in/gc9_DYdx
BenchSci Named To The Globe and Mail's Canada's Top Growing Companies 2024 List
benchsci.com
-
Our Co-founder and Chief Science Officer, Tom Leung, MSc PhD, recently shared his inspiring journey on the How I Became Podcast podcast with Kelly Yefet 🎙️ Tom candidly discusses his PhD struggles in finding reliable antibodies—the spark that ignited the idea for BenchSci. He emphasizes how a diverse team, blending scientific understanding with business acumen and AI expertise, was crucial to the company's success. For aspiring entrepreneurs, Tom's story is a testament to the power of identifying real-world problems and pursuing innovative solutions. Tune in to hear how this unique blend of talents fueled BenchSci's innovation and growth. 🎧 Apple: https://lnkd.in/eWg64-iE 🎧 Spotify: https://lnkd.in/e43UYemF 🎧 YouTube: https://lnkd.in/eqyxjCg4
#32 - Tom Leung, MSc PhD [Undesigned Path], Founder, BenchSci
podcasts.apple.com
-
Our CEO and Co-founder, Liran Belenzon (he/him), was featured on the latest episode of SiriusXM's #TheFeed with Amber Mac and Michael Bancroft. During their conversation, they explore how AI is helping scientists develop new drugs, and Liran shares his insights on: ✔ The importance of building an AI platform in collaboration with scientists ✔ How BenchSci’s ASCEND platform is tackling the complexities of disease biology at scale ✔ The future of AI and drug discovery 🎧[25:26 mark] https://lnkd.in/d2vNcJr4
#TheFeed: ChatGPT Becoming More Human Changing Reproductive Health
https://ambermac.com
-
AI assistants have the potential to revolutionize pharmaceutical research, but they must be designed for the needs of scientists, not just the scientific data. To empower scientists in this complex field, AI assistants need to go beyond basic conversation and cater to their unique challenges and complex workflows. Our latest blog post delves into why tailored AI solutions are crucial for pharma R&D, highlighting: ➡️ The challenges of applying generic AI tools in this specialized field ➡️ Key factors that can influence the design and effectiveness of AI solutions for scientists ➡️ The value of continuous discovery and validation to fuel innovation ➡️ The importance of building trust through transparency and explainability ➡️ How BenchSci's user-centric approach combines GenAI with intuitive GUIs to create a powerful, trusted tool for scientists Read the full blog: https://lnkd.in/eMubzq92 #AI #Pharma #DrugDiscovery #BenchSci
Why Pharma AI Assistants Need to be Designed for Scientists
blog.benchsci.com
-
What does it take to build a successful startup? Our CEO and Co-founder, Liran Belenzon (he/him), recently sat down with Philip Bliss on Canada's Podcast to discuss his entrepreneurial journey and the story behind BenchSci. He also shared valuable lessons and advice for anyone looking to build a successful company. Tune in to hear Liran’s insights on: ✔ The realities of startup life ✔ Building a strong, high-performing team ✔ Navigating the fundraising landscape ✔ Overcoming challenges and setbacks Listen now: 🎧 Apple: https://shorturl.at/1Kg6c 🎧 Spotify: https://shorturl.at/wpPrm 💻 YouTube: https://shorturl.at/GCmw0
-
We’re proud to announce our new partnership with The Company of Biologists. This collaboration integrates publications from their top journals into our AI-powered platform, ASCEND, giving scientists streamlined access to vital research including open and closed-access publications. Today, most scientists rely on the world’s scientific findings to advance scientific discovery. However, the increasing volume of research (over 1.5 million new articles annually) makes extracting up-to-date and reliable information a significant challenge. This often leads to unnecessary experimental errors and missed research opportunities. This partnership addresses this key challenge and empowers scientists with greater access to documented research, accelerating their work in drug discovery. Learn more about our partnership with The Company of Biologists and how we're empowering scientists across preclinical R&D: https://lnkd.in/eiAg5JDz
-
Thank you, Jonathan Shriftman, for featuring us in your latest deep dive, “Transforming Code, Care & Classrooms with AI.” This article explores how AI is transforming industries, including healthcare. Jonathan emphasizes AI’s potential to augment human capabilities, a vision we’re actively realizing with our ASCEND platform—an AI assistant for preclinical scientists. ASCEND empowers scientists to unravel the complexities of disease biology at scale, helping them uncover hidden biological connections, predict experimental outcomes, and make informed decisions. By streamlining the research process and breaking down barriers, we're accelerating the path to groundbreaking discoveries and life-saving therapies. Thank you, Jonathan, for this insightful look at the future of AI. To learn more from our CEO and Co-Founder, Liran Belenzon (he/him), read the full article here: https://lnkd.in/gfvDCXRp
Transforming Code, Care & Classrooms with AI
shriftman.substack.com
-
Leadership, entrepreneurship, and the power of taking risks are just a few topics explored in the latest Inspiring Leadership podcast, featuring our Co-founder and CEO, Liran Belenzon (he/him). Liran discusses the challenges and rewards of entrepreneurship, the importance of perseverance, and how these experiences have shaped his leadership style. Tune in to hear Liran's inspiring conversation with Jonathan Bowman-Perks MBE ⬇ 🎧 Apple: https://bit.ly/3T0hCx5 🎧 Spotify: https://spoti.fi/4fVgKU7 💻 YouTube: https://bit.ly/474jeMc
#329: Be a Learner not a Knower with Liran Belenzon
podcasts.apple.com
-
We were thrilled to welcome back Jessica Neal, a renowned culture builder, for another insightful Scale Up talk! Jessica, the former Chief Talent Officer at Netflix and current Venture Partner at TCV, has a wealth of knowledge about fostering a culture that drives growth and innovation. As a cohost of the popular TruthWorks podcast, Jessica is usually the one asking the questions, but this time, our team was fortunate to hear Jessica’s perspective, stories, and lessons learned throughout her impressive career. In our latest blog post, BenchSci’s VP of Talent, Nika Stelman shares what resonated the most to her during their conversation. https://lnkd.in/gYkN_EdZ
How to Scale Up with Jessica Neal
blog.benchsci.com